Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer

Molecular Endocrinology

Volumn 14, Issue 9, 2000, Pages 1434-1447

  Razandi, M ^a   Pedram, A ^a   Levin, E R ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ESTROGEN RECEPTOR; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PROTEIN BCL 2; PROTEIN BCL X; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL MEMBRANE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

EID: 0033732896     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.9.0526     Document Type: Article

References (63)

1. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
2. Mechanisms of growth control in normal and malignant breast epithelium
3. Treatment of metastatic breast cancer
4. Ovarian ablation as adjuvant therapy for early-stage breast cancer
5. A randomized phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer
6. Tamoxifen for early breast cancer: An overview of the randomized trials
7. Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis
8. Mechanisms and genes of cellular suicide
9. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
10. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells
11. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells
12. POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element
13. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
14. Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes
15. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-α production in SLE but not in normal cultures
16. Cytokines, bone remodeling, and estrogen deficiency: A 1998 update
17. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription
18. Estrogen and progesterone inhibit human vascular smooth muscle proliferation
19. Cell membrane and nuclear estrogen receptors derive from a single transcript: Studies of ERα and ERβ expressed in CHO cells
20. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
21. Extracellular regulated kinase/jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation
22. Inactivation of Bcl-2 by phosphorylation
23. Involvement of microtubules in the regulation of Bcl-2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
24. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
25. Bcl-2 phosphorylation required for anti-apoptosis function
26. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
27. Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats
28. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease
29. Programmed cell death in animal development
30. Ovarian follicle atresia: A hormonally controlled apoptotic process
31. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow up from the Nurses Health Study
32. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts
33. Estrogen receptor a mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
34. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism
35. Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells
36. Differential effects of estradiol and estradiol-BSA conjugates
37. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor β
38. Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2
39. Paclitaxel (taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK)
40. Double identity for proteins of the Bcl-2 family
41. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
42. Caspases: Intracellular signaling by proteolysis
43. RGD peptides induce apoptosis by direct caspase-3 activation
44. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
45. Bcl-2 targets the protein kinase Raf-1 to mitochondria
46. Functional synergy between the transcription factor Sp1 and the estrogen receptor
47. Identification of a novel regulatory domain in Bcl-X(L)and Bcl-2
48. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1
49. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-xl in response to DNA damage
50. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
51. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
52. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
53. The mitogen-activated protein kinase signal transduction pathway
54. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats
55. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade
56. The mitogen activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
57. Regulation of bad phosphorylation and association with Bcl-xl by the MAP/Erk kinase
58. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms
59. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
60. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase
61. Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells
62. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
63. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion